ZIMMER BIOMET HOLDINGS, INC. (ZBH) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 3.01B USD | Liabilities, Current |
| Cash and equivalents | 410.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 1.77B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 2.27B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.01B | $410.00M | (m) | $1.77B | $2.27B | (m) |
| 2026-03-31 | (m) | $2.86B | $424.20M | (m) | $1.73B | $2.25B | (m) |
| 2025-12-31 | (m) | $2.58B | $591.90M | (m) | $1.70B | $2.29B | (m) |
| 2025-09-30 | (m) | $2.40B | $1.29B | (m) | $1.60B | $2.48B | (m) |
| 2025-06-30 | (m) | $2.70B | $556.90M | (m) | $1.61B | $2.45B | (m) |
| 2025-03-31 | (m) | $2.29B | $1.38B | (m) | $1.53B | $2.24B | (m) |
| 2024-12-31 | (m) | $2.45B | $525.50M | (m) | $1.48B | $2.24B | (m) |
| 2024-09-30 | (m) | $3.57B | $569.00M | (m) | $1.48B | $2.37B | (m) |
| 2024-06-30 | (m) | $3.61B | $420.10M | (m) | $1.42B | $2.37B | (m) |
| 2024-03-31 | (m) | $2.80B | $393.00M | (m) | $1.45B | $2.39B | (m) |
| 2023-12-31 | (m) | $2.86B | $415.80M | (m) | $1.44B | $2.39B | (m) |
| 2023-09-30 | (m) | $2.07B | $292.10M | (m) | $1.34B | $2.32B | (m) |
| 2023-06-30 | (m) | $2.23B | $319.80M | (m) | $1.37B | $2.28B | (m) |
| 2023-03-31 | (m) | $2.34B | $330.20M | (m) | $1.38B | $2.24B | (m) |
| 2022-12-31 | (m) | $2.36B | $375.70M | (m) | $1.38B | $2.15B | (m) |
| 2022-09-30 | (m) | $2.30B | $545.40M | (m) | $1.28B | $2.13B | (m) |
| 2022-06-30 | (m) | $2.46B | $386.40M | (m) | $1.28B | $2.12B | (m) |
| 2022-03-31 | (m) | $2.67B | $435.80M | (m) | $1.25B | $2.13B | (m) |
| 2021-12-31 | (m) | $3.47B | $478.50M | (m) | $1.40B | $2.39B | (m) |
| 2021-09-30 | (m) | $2.94B | $919.60M | (m) | $1.39B | $2.52B | (m) |
| 2021-06-30 | (m) | $2.93B | $1.04B | (m) | $1.42B | $2.53B | (m) |
| 2021-03-31 | (m) | $2.09B | $724.30M | (m) | $1.38B | $2.51B | (m) |
| 2020-12-31 | (m) | $2.56B | $802.10M | (m) | $1.45B | $2.45B | (m) |
| 2020-09-30 | (m) | $2.27B | $967.30M | (m) | $1.34B | $2.49B | (m) |
| 2020-06-30 | (m) | $2.16B | $713.40M | (m) | $1.06B | $2.50B | (m) |
| 2020-03-31 | (m) | $3.78B | $2.43B | (m) | $1.04B | $2.46B | (m) |
| 2019-12-31 | (m) | $3.44B | $617.90M | (m) | $1.36B | $2.38B | (m) |
| 2019-09-30 | (m) | $3.77B | $512.50M | (m) | $1.15B | $2.36B | (m) |
| 2019-06-30 | (m) | $3.68B | $403.10M | (m) | $1.25B | $2.34B | (m) |
| 2019-03-31 | (m) | $2.25B | $586.80M | (m) | $1.23B | $2.31B | (m) |
| 2018-12-31 | (m) | $2.42B | $542.80M | (m) | $1.28B | $2.26B | (m) |
| 2018-09-30 | (m) | $2.39B | $524.60M | (m) | $1.26B | $2.22B | (m) |
| 2018-06-30 | (m) | $1.85B | $481.20M | (m) | $1.34B | $2.16B | (m) |
| 2018-03-31 | (m) | $3.42B | $1.77B | (m) | $1.42B | $2.13B | (m) |
| 2017-12-31 | (m) | $3.02B | $524.40M | (m) | $1.49B | $2.08B | (m) |
| 2017-09-30 | (m) | $3.01B | $480.80M | (m) | $1.32B | $2.08B | (m) |
| 2017-06-30 | (m) | $3.00B | $450.00M | (m) | $1.42B | $2.02B | (m) |
| 2017-03-31 | (m) | $2.66B | $1.04B | (m) | $1.60B | $1.98B | (m) |
| 2016-12-31 | (m) | $2.38B | $634.10M | (m) | $1.60B | $1.96B | (m) |
| 2016-09-30 | $2.09B | $2.31B | $475.30M | $13.40M | $1.60B | $2.07B | 0.90× |
| 2016-06-30 | (m) | $2.10B | $976.30M | (m) | $1.59B | $1.96B | (m) |
| 2016-03-31 | $2.58B | $1.51B | $996.80M | $13.40M | $1.57B | $2.08B | 1.70× |
| 2015-12-31 | $3.07B | $1.62B | $1.46B | $164.60M | $1.45B | $2.25B | 1.90× |
| 2015-09-30 | $3.20B | $1.79B | $1.47B | $343.30M | $1.39B | $2.36B | 1.79× |
| 2015-06-30 | $3.37B | $2.16B | $1.42B | $459.00M | $1.49B | $2.44B | 1.56× |
| 2015-03-31 | $10.15B | $908.70M | $8.79B | $488.40M | $869.80M | $1.22B | 11.17× |
| 2014-12-31 | $2.61B | $1.04B | $1.08B | $612.50M | $912.10M | $1.17B | 2.51× |
| 2014-09-30 | $2.69B | $1.09B | $967.30M | $779.80M | $947.60M | $1.18B | 2.47× |
| 2014-06-30 | $2.65B | $952.90M | $968.70M | $729.30M | $950.20M | $1.15B | 2.78× |
| 2014-03-31 | $2.53B | $918.70M | $882.70M | $705.40M | $939.10M | $1.13B | 2.75× |
| 2013-12-31 | $2.74B | $1.03B | $1.08B | $727.00M | $936.60M | $1.07B | 2.66× |
| 2013-09-30 | $2.40B | $804.20M | $917.40M | $588.40M | $898.90M | $1.08B | 2.99× |
| 2013-06-30 | $2.18B | $804.30M | $709.90M | $525.90M | $942.50M | $1.05B | 2.71× |
| 2013-03-31 | $2.11B | $763.30M | $657.00M | $544.20M | $912.50M | $1.04B | 2.77× |
| 2012-12-31 | $2.44B | $866.00M | $884.30M | $671.60M | $884.60M | $995.30M | 2.82× |
| 2012-09-30 | $2.36B | $755.50M | $801.50M | $687.40M | $874.90M | $994.10M | 3.13× |
| 2012-06-30 | $2.24B | $683.10M | $651.00M | $684.90M | $906.70M | $956.00M | 3.28× |
| 2012-03-31 | $2.12B | $861.80M | $674.00M | $555.10M | $895.00M | $937.00M | 2.46× |
| 2011-12-31 | $2.06B | $867.10M | $768.30M | $455.50M | $838.80M | $929.80M | 2.38× |
| 2011-09-30 | $1.81B | $674.60M | $553.00M | $424.90M | $827.90M | $968.40M | 2.68× |
| 2011-06-30 | $1.83B | $679.00M | $624.10M | $321.40M | $888.40M | $975.10M | 2.70× |
| 2011-03-31 | $1.74B | $713.40M | $575.60M | $290.60M | $876.30M | $958.40M | 2.44× |
| 2010-12-31 | $1.71B | $702.50M | $668.90M | $265.10M | $775.90M | $936.40M | 2.43× |
| 2010-09-30 | $1.74B | $698.60M | $918.60M | $63.00M | $757.80M | $925.40M | 2.49× |
| 2010-06-30 | (m) | $601.80M | $953.70M | (m) | $765.10M | $885.80M | (m) |
| 2010-03-31 | (m) | $655.20M | $821.20M | (m) | $767.10M | $896.50M | (m) |
| 2009-12-31 | (m) | $690.70M | $691.70M | (m) | $751.40M | $913.20M | (m) |
| 2009-09-30 | (m) | $676.70M | $439.70M | (m) | $743.20M | $972.10M | (m) |
| 2009-06-30 | (m) | $669.20M | $277.50M | (m) | $768.70M | $980.90M | (m) |
| 2009-03-31 | (m) | (m) | $212.80M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $771.10M | $212.60M | (m) | $732.80M | $928.30M | (m) |
| 2008-09-30 | (m) | (m) | $542.40M | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $388.10M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $463.90M | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | $265.70M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |